Sino Biopharmaceutical Updates Board Composition and Committee Structure

Bulletin Express06-17

On 17 June 2026, Sino Biopharmaceutical Limited announced an updated list of directors and detailed their roles across five board committees. The Board now comprises five executive directors and six independent non-executive directors, with Ms. Theresa Y. Y. Tse serving as Chairwoman.

Executive Directors • Theresa Y. Y. Tse (Chairwoman) • Tse Ping (Senior Vice Chairman) • Cheng Cheung Ling (Vice Chairwoman) • Eric S. Y. Tse (Chief Executive Officer) • Tse Hsin

Independent Non-executive Directors • Lu Zhengfei • Lu Hong • Zhang Lu Fu • Dr. Li Kwok Tung Donald • Dr. Chen Lieping • Dr. Lu Bai

Committee Leadership and Membership • Executive Board Committee: Chaired by Theresa Y. Y. Tse • Audit Committee: Chaired by Lu Zhengfei • Remuneration Committee: Chaired by Zhang Lu Fu • Nomination Committee: Chaired by Cheng Cheung Ling • Environmental, Social and Governance Committee: Chaired by Theresa Y. Y. Tse

Each director’s committee memberships were also disclosed, underscoring the company’s emphasis on governance transparency and oversight.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment